companies

Dawn Health

Founded 2016
Employees 100+
Primary contact
Sundkaj 153
2150 Copenhagen
Denmark
Links
https://dawnhealth.com/
Diseases & Conditions
Dawn Health develops digital health products to improve the lives of patients around the world living with chronic diseases, specializing in the development of software as a medical device (SaMD) and digital therapeutics (DTx). To that end, the company builds strong partnerships with industry leaders through ongoing collaboration throughout the entire production process. Dawn Health's different solutions address conditions such as diabetes, schizophrenia, male reproductive health, obesity, growth hormone deficiency, and hypertension. In addition to its headquarters in Copenhagen, the company also has an office in Zurich, Switzerland.
Select partners: Microsoft, Apple, Trifork, Prevas, TPU, Novartis, Pfizer, Novo Nordisk, Janssen, Ferring Pharmaceuticals, Takeda, Novozymes.
Founded 2016
Employees 100+
Primary contact
Sundkaj 153
2150 Copenhagen
Denmark
Links
https://dawnhealth.com/
Diseases & Conditions

Funding 💰

Total $25M
Last round 🔗 $25M
Series A
December 1, 2021.
Select investors Chr. Augustinus Fabrikker, Vaekstfonden

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Enabling faster time to market: The Dawn Platform is specialized for regulated digital health products, and compliance is woven through our entire ecosystem. With its agile approach and through automation and pre-built foundational modules, it accelerates these fundamental components of digital health products for faster time to market.
  • Standards and certifications: Dawn's digital health solutions adhere to several standards, such as ISO 13485:2016 (Quality Management for Medical Devices), ISO 14971 (Application of Risk Management to Medical Devices), IEC 62304 (Medical Device Software Lifecycle Processes), ISO/IEC 27001 (Information Security Management), GAMP5 (A Risk-Based Approach to Compliant GxP Computerized System), IEC 82304 (Health Software Product Safety), IEC 62366 (Medical Device Usability), and UL-2900-2-1 (Software Cybersecurity). 🔗
  • Bold goal: The company's mission is to bring research, care and technology together with the aim of helping 1 million people live longer and better lives by 2030.

Video ▶️

Quotes 💬

“
Digitization of medical devices is a global megatrend, and Dawn has both the knowledge and ambitions to play an important role. We are very impressed with the team behind Dawn Health, and we look forward to help realizing the great potential of digital healthcare products for the benefit of us all. Investments in ambitious Danish startups are an important part of Chr. Augustinus Fabrikker's scale investment strategy, and we have allocated more than DKK 1 billion to new innovative companies with an international outlook such as Dawn Health.
— Claus Gregersen, CEO of Chr. Augustinus Fabrikker 🔗
“
Denmark has a unique potential to create new market leaders within the global health tech industry, and Dawn Health is a prime example of this. Digitizing the health sector is crucial for creating a stronger and better global healthcare system. And we need innovative companies like Dawn Health to drive this transformation. That is why we are excited to be able to back Dawn Health's journey towards becoming a global market leader, building on their strong roots in Denmark and the local ecosystem.
— Rolf Kjærgaard, CEO of Vaekstfonden 🔗
“
Dawn Health is a unique company with a strong innovation platform with high global scalability in the rapid changing space of digital health. With significant opportunities, strong leadership and dedicated employees I look forward to the transformative journey together with my highly experienced board colleagues.
— Lars Marcher, investor and Dawn Health's Chairman of the Board 🔗
Last update: March 8, 2023